USSTOCK.TODAY
Regular Market
Log in Sign up

Regeneron Pharmaceuticals Inc(REGN) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today

REGN
Regeneron Pharmaceuticals Inc
At close September 10 at 12:40 PM ET (Korea 9/11 01:40)
$807.65
-2.66 ▼ -0.33%
Resistance - Support - Lines drawn by AI for reference. They may be wrong. Treat them as a hint, not a forecast.

Full metrics table

C
Fundamental health
vs. Biotechnology 대형주
How profitably the company operates. ⓘ
Top 36%
How fast earnings and revenue are growing. ⓘ
Top 52%
Whether the stock is cheap or expensive relative to fundamentals. ⓘ
Top 77%
Whether the company can weather downturns without a heavy debt burden. ⓘ
Top 48%
💰 Is this stock pricier than usual right now? ⓘ
Compared to this company's own recent 5Y (not other companies).
Very cheap
Cheap
Typical
Pricey
Very pricey
Simply put. What you pay today to own $1 of this company's yearly earnings is 19 KRW. Over the past 5Y, it usually traded around 17 KRW. On the pricier side versus its own history.
Pricy doesn't mean bad. It means expectations are already baked in.
Index ⓘ NDX, S&P 500P/E ⓘ 19.96EPS (ttm) ⓘ 40.46Insider Own ⓘ 3.74%Shs Outstand ⓘ 101.6MPerf Week ⓘ -1.96%
Market Cap ⓘ 83.15BForward P/E ⓘ 13.25EPS next Y ⓘ 12.34%Insider Trans ⓘ -0.11%Shs Float ⓘ 99.1MPerf Month ⓘ -0.05%
Enterprise Value ⓘ 77.85BPEG ⓘ 0.86EPS next Q ⓘ 16.04Inst Own ⓘ 91.7%Short Float ⓘ 2.42%Perf Quarter ⓘ 31.07%
Income ⓘ 4.33BP/S ⓘ 5.35EPS this Y ⓘ 22.45%Inst Trans ⓘ -0.39%Short Ratio ⓘ 2.87Perf Half Y ⓘ 4.61%
Sales ⓘ 15.53BP/B ⓘ 2.63EPS next 5Y ⓘ 15.44%ROA ⓘ 10.83%Short Interest ⓘ 2.40MPerf YTD ⓘ 4.64%
Book/sh ⓘ 306.69P/C ⓘ 10.39EPS past 3/5Y ⓘ 2.76% 6.33%ROE ⓘ 14.04%52W High ⓘ -6.02% ($859.34)Perf Year ⓘ 45.12%
Cash/sh ⓘ 77.75P/FCF ⓘ 22.11Sales past 3/5Y ⓘ 5.62% 11.04%ROIC ⓘ 12.85%52W Low ⓘ 49.29% ($541.00)Perf 3Y ⓘ -2.77%
Dividend Est. ⓘ $3.93 (0.49%)EV/EBITDA ⓘ 16.56EPS Y/Y TTM ⓘ 0.38%Gross Margin ⓘ 81.46%Volatility(W/M) ⓘ 2.64% 2.42%Perf 5Y ⓘ 25%
Dividend TTM ⓘ 3.7EV/Sales ⓘ 5.01Sales Y/Y TTM ⓘ 9.29%Oper. Margin ⓘ 26.87%ATR (14) ⓘ 20.48Perf 10Y ⓘ 110.09%
Dividend Ex-Date ⓘ 2026/8/18Quick Ratio ⓘ 2.78EPS Q/Q ⓘ -4.52%Profit Margin ⓘ 27.86%RSI (14) ⓘ 53.66Recom ⓘ 1.93
Dividend Gr. 3/5Y ⓘ -Current Ratio ⓘ 3.34Sales Q/Q ⓘ 16.73%SMA20 ⓘ -1.31% ($818.37)Beta ⓘ 0.15Target Price ⓘ $854.29
Payout ⓘ 8.49%Debt/Eq ⓘ 0.09Earnings ⓘ 2026/7/30SMA50 ⓘ 8.42% ($744.93)Rel Volume ⓘ 0.67Prev Close ⓘ $810.31
Employees ⓘ 15410LT Debt/Eq ⓘ 0.06EPS/Sales Surpr. ⓘ 40.69% 12.4%SMA200 ⓘ 10.17% ($733.09)Avg Volume(3M) ⓘ 0.84MPrice ⓘ $807.65
IPO ⓘ 1991/4/2Option/Short ⓘ Yes/YesTrades ⓘ 19079Volume ⓘ 563,433Change ⓘ -0.33%

Company

리제네론 파마슈티컬스REGN | NASD | Biotechnology Details

REGN is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

🧬 Regeneron Pharmaceuticals (REGN) is a major US biotech company that has developed innovative new drugs across a broad range of areas—including ophthalmology, immunology, oncology, cardiovascular, and rare diseases—based on its proprietary antibody discovery platform. The company has a stable revenue foundation built around two main pillars: Eylea and its high-dose Eylea formulation for the treatment of macular degeneration, and Dupixent, the immunology blockbuster co-commercialized with Sanofi.

Quote

Over the past 1 year, on the higher side

6% below its 1-year high.

Day low$796.72Day high$808.63
52w low$541.0052w high$859.34
Open$803.83
Volume563,433
Close$807.65
52W Range84%
A
5 of 8 metrics rate excellent
ETFs holding this stock 5 places

Multiple ETFs hold this stock

Buying this ETF gives you exposure to this stock as well.

ETFs holding this stockWeight
TBXU 0.09%
HCOW 0.07%
XRPI 0.07%
SOLZ 0.07%
THNR 0.07%
Peer comparison Biotechnology

It ranks #2 in the industry

Based on market cap of $83B.

REGN $83B PER 20.0
VRTX $132B PER 30.3
ARGX $63B PER 38.2
MRNA $54B PER -
Reads on this stock 2 posts
실적분석 · 7/30 Regeneron Pharmaceuticals ($REGN) Q2 2026 Earnings Analysis — Adjusted EPS and Revenue Both Beat by Wide Margins, After-Hours Strength 투자 가이드 · 4/1 US Stock Taxes Complete Guide 2026 — Calculation Methods and Tax-Saving Strategies for Beginners
FAQ

FAQ

What kind of company is REGN?

REGN belongs to the Healthcare sector and operates in the Biotechnology industry.

What is the market cap of REGN?

The market cap of REGN is approximately $83.2B, ranking 205 within its sector.

Does REGN pay dividends?

REGN has a dividend yield of approximately 0.49%, with an annual dividend of $3.93.

What is the P/E ratio of REGN?

REGN has a P/E ratio of approximately 20.0x, which can be used to assess its valuation relative to the Healthcare sector average.

What is the 52-week high and low for REGN?

REGN has recorded a 52-week high of $859.34 and a low of $541.00.

Telegram KakaoTalk
Briefs · earnings · signals, first Telegram · KakaoTalk channels